Skip to Content
US Videos

A Rare, Wide-Moat Find in a Market With Few Values

Investors concerned with Express Scripts' integration of Medco are overlooking the firm's long-term potential to benefit from an increased focus on health-care cost-cutting, says Morningstar StockInvestor editor Matt Coffina.

Mentioned: , , ,

Jeremy Glaser: For Morningstar, I'm Jeremy Glaser. In a market with few bargains, Morningstar StockInvestor editor Matt Coffina sees Express Scripts as a rare value. He's here today to talk to me about his outlook for the firm. Matt, thanks for joining me.

Matt Coffina: Thanks for having me, Jeremy.

Jeremy Glaser does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.